U.S. Food and Drug Administration Commissioner Marty Makary speaks at a Nov. 10 news conference at the Department of Health and Human Services in Washington, D.C.
Elizabeth Frantz, REUTERS
U.S. President Donald Trump shakes hands with Health and Human Services Secretary Robert F. Kennedy Jr. on April 18 while Americans for Ibogaine CEO W. Bryan Hubbard, podcaster Joe Rogan and Food and Drugs Administration head Marty Makary are present for Trump's signing of an executive order about easing restrictions on mental health treatments, including, ibogaine, in the Oval Office of the White House in Washington, D.C.
WASHINGTON — U.S. FDA Commissioner Marty Makary resigned, President Donald Trump said Tuesday, after weeks of clashing with top White House and health advisers and drawing scrutiny for a series of controversial agency decisions, according to several people familiar with internal dynamics.
U.S. Food and Drug Administration Commissioner Marty Makary speaks at a Nov. 10 news conference at the Department of Health and Human Services in Washington, D.C.
U.S. President Donald Trump shakes hands with Health and Human Services Secretary Robert F. Kennedy Jr. on April 18 while Americans for Ibogaine CEO W. Bryan Hubbard, podcaster Joe Rogan and Food and Drugs Administration head Marty Makary are present for Trump's signing of an executive order about easing restrictions on mental health treatments, including, ibogaine, in the Oval Office of the White House in Washington, D.C.
